Skip to Content
Merck
  • Formulation and bioequivalence of two Valsartan/Amlodipine immediate release tablets after a single oral administration.

Formulation and bioequivalence of two Valsartan/Amlodipine immediate release tablets after a single oral administration.

Pakistan journal of pharmaceutical sciences (2014-07-13)
Abdel Naser Zaid, Salam Natur, Aiman Qaddomi, Murad Abualhasan, Rowa Al-Ramahi, Naser Shraim, Saed Khammash, Nidal Jaradat
ABSTRACT

The aim of this study was to formulate a film-coated Valsartan/Amlodipine (VS/AM) immediate release tablets and to evaluate their in vivo release profile. VS/AM core tablets were manufactured using dry granulation method. Opadry aqueous coating dispersion was used as film coating material. Dissolution of the film coated tablets was tested in 900 ml of 0.5% SLS media, bioequivalence of tablets was tested by comparisons against the reference brand product. The ICH guidelines were used to evaluate the stability of the obtained tablets. The coated tablets were subjected to gastric pH, and drug release was analyzed using HPLC system to evaluate the efficiency of the film coat. The coated tablets had no defects. VS/AM release met the FDA guidelines for bioequivalence studies. Statistical comparison of the main pharmacokinetic parameters showed no significant difference between test and reference. These findings suggest that aqueous film coating with Opadry system is an easy and economical approach for preparing stable film coated VS/AM tablets without compromising their in vivo drugs release.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Amlodipine besylate, ≥98% (HPLC)
Amlodipine for peak identification, European Pharmacopoeia (EP) Reference Standard
USP
Amlodipine besylate, United States Pharmacopeia (USP) Reference Standard
Supelco
Amlodipine besylate, Pharmaceutical Secondary Standard; Certified Reference Material
Amlodipine besylate, European Pharmacopoeia (EP) Reference Standard